XEME Biopharma Holdings Inc.

Qualified
CIK: 1775196•FL•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2834

$40M
Qualified
maximum offering price, as qualified
$100.00
Reported Sold
1-K 2020-06-29
11
Filings
across 4 offerings

Equity Classes

TypeClassOutstanding
commonClass A914,591,800
commonClass B40,000,000

Service Providers

RoleProvider
auditorParis, Kreit & Chiu CPA LLP
blue skyState filing
legalClifford J Hunt P.A

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedEstimated NetWithdrawn
024-1099682019-05-072021-12-222019-11-052020-02-06$0.20100,000,0000100,000,000954,591,800$20M$100.00$20M2019-10-29
024-1109712019-10-152019-10-15——$0.20100,000,000——4,130,000$0———
024-1108212019-09-252019-09-25——$0.20100,000,000——4,130,000$20M———

Current Reports

Filing DateFormEventItems
2020-08-071-UChange in Control1,6,7,8,9.1
2020-06-021-UChange of Auditor4,9.1
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings